1. Japan Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Tri Chemical Laboratories Inc.

Tri Chemical Laboratories Inc.

4369.T
Tri Chemical Laboratories Inc.JP flagTokyo Stock Exchange
3,440.00
JPY
-195.00
- -
111.79BMarket Cap
Tri Chemical Laboratories Inc.
4369.T
(Tokyo Stock Exchange)

Recent

price

3,440.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
113
140.86
112.35
116.92
140.63
161.76
175.19
206.28
249.37
264.58
313.69
357.07
424.76
346.09
581.77
734.95
418.53
Revenue per Share
5.49
6.17
0.55
2.35
12.36
15.44
24.57
36.66
72.56
94.08
108.08
126.33
148.7
76.03
152.69
169.72
93.83
Basic EPS, GAAP
16.3
7.84
-0.54
-7.15
1.07
-3.4
20.11
5.3
5.84
7.9
-27.91
83.51
148.8
36.66
18.19
-78.15
-34.06
Free Cash Flow per Basic Share
- -
1.24
1.23
- -
0.49
1.71
2.48
3.99
5.25
11.2
14.53
16.38
19.99
29.97
29.99
34.98
30.01
Dividend per Share
61.67
62.87
61.66
64.05
76.15
86.9
81.57
114.17
203.51
286.34
379.93
552.39
679.69
725.76
848.41
983.15
758.37
Book Value per Share
81.95
84.86
83.89
86.66
99.6
110
130.26
161.41
222.59
300.47
396.61
652.14
792.11
845.2
969.73
1,109.67
882.95
Tangible Book Value per Share
28
28
29
29
29
31
31
31
31
31
31
32
32
32
32
32
32
Basic Weighted Avg Shares
3,193
4,002
3,218
3,362
4,103
4,957
5,470
6,446
7,792
8,267
9,802
11,574
13,803
11,246
18,906
23,883
13,598
Sales/Revenue/Turnover
7.39
8.1
1.23
1.4
8.56
14.56
17.86
24.79
27.63
28.15
27.46
25.71
25.39
17.32
27.8
24.71
20.49
Operating Margin (%)
255
254
268
251
235
266
338
373
484
642
814
1,019
1,210
1,305
1,372
1,917
1,339
Depreciation Expense
155
175
16
68
361
473
767
1,146
2,267
2,940
3,377
4,095
4,832
2,471
4,962
5,515
3,049
Net Income, GAAP
28.23
41.93
53.6
30.42
37.49
31.77
31.39
29.47
22.66
21.49
21.88
22.66
21.89
24.6
24.63
22.21
24.74
Effective Tax Rate (%)
4.86
4.38
0.49
2.01
8.79
9.55
14.03
17.77
29.1
35.56
34.46
35.38
35.01
21.97
26.25
23.09
22.42
Profit Margin (%)
556
661
802
1,079
1,612
2,012
2,138
1,712
2,869
3,097
4,294
10,921
15,247
16,455
17,274
15,649
16,439
Working Capital
316
326
358
351
566
838
1,040
1,123
1,406
2,360
3,762
3,232
2,368
1,597
1,019
3,363
1,043
LT Debt
2,323
2,418
2,408
2,497
2,911
3,375
4,071
5,089
7,026
9,582
12,601
21,320
25,876
27,570
31,588
36,150
28,773
Total Equity
4.54
4.91
0.47
0.84
5.09
9.74
11.46
16.07
18.69
15.38
13.2
10.31
9.72
4.89
12.22
12.13
6.93
Return on Invested Capital (%)
5.39
5.83
0.7
2.38
10.44
11.54
17.07
22.13
30.62
27.46
23.12
21.07
20.43
9.7
18
16.94
11.97
Return on Capital (%)
9.3
9.93
0.88
3.74
17.75
19.38
29.46
37.47
45.68
38.41
32.44
27.5
24.17
10.82
19.4
18.53
12.92
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jan'24
Apr'25
Jul'25
ST Debt
803
714
690
LT Borrowings
1,213
1,210
1,043
LT Finance Leases
384
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
32
32
32
Market Capitalization
119,914
144,097
121,353

Working Capital

FRC

•

in mil. unless spec.
Jan'24
Apr'25
Jul'25
Total Current Assets
19,009
20,022
19,666
Cash, Cash Equivalents & STI
10,497
11,154
9,531
Accounts Receivable, Net
2,687
2,378
3,861
Inventories
4,023
4,744
4,439
Total Current Liabilities
2,554
4,392
3,227
Payables & Accruals
- -
- -
- -
ST Debt
803
714
690
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
27.77%
25.22%
14.44%
Free Cash Flow
-217.05%
-197.41%
-529.61%
Net Income, GAAP
35.63%
20.48%
11.15%
Sales/Revenue/Turnover
18.7%
22.65%
26.33%
Total Cash Common Dividend
38.89%
21.19%
16.65%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
3,275
4,700
- -
- -
18,906
2026
- -
- -
- -
- -
23,883
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
25
- -
- -
- -
152.69
2026
- -
- -
- -
- -
169.72
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
28.53
- -
- -
- -
29.99
2026
- -
- -
- -
- -
34.98
2027
- -
- -
- -
- -
- -
Similar Companies
Riken Corundum Company Limited. (5395.T)
Cleantech Biofuels, Inc. (CLTH)
Nocopi Technologies, Inc. (NNUP)
Fuchs Petrolub SE (FPE.DE)
Pidilite Industries Limited (PIDILITIND.BO)
Jiangsu Innovative Ecological New Materials Limited (2116.HK)
Business
Tri Chemical Laboratories Inc. (4369.T) develops, manufactures and sells high-purity chemicals primarily for semiconductor manufacturing processes; its core products include chemical vapor deposition (CVD) materials such as precursors for tantalum (Ta), titanium (Ti), tungsten (W), hafnium (Hf) and molybdenum (Mo), dry etching materials, diffusion materials and materials for compound semiconductors, optical fibers and solar cells; the company also produces catalysts, special reagents and provides custom synthesis, chemical analysis, film deposition testing services including atomic layer deposition (ALD) and plasma-enhanced CVD, as well as specialized containers and piping cleaning solutions. Founded in December 1978 and headquartered in Uenohara-shi, Yamanashi Prefecture, Japan, the company operates through subsidiaries Tri Chemical Electronic Materials Taiwan Inc. in Taiwan and Tri Chemical Laboratories China Inc. in Shanghai, with a sales office in South Korea and affiliates including joint ventures HBR Co., Ltd. and SK Tri Chem Co., Ltd., serving global semiconductor, electronics and advanced materials markets primarily in Asia. Recent developments include the announcement in August 2025 of a new joint venture establishment in China to expand production capabilities, construction of a new plant as updated in April 2025, revisions to full-year financial forecasts alongside strong first-half results for the fiscal year ending January 2026 reported in late August 2025, and ongoing research projects such as new Ta, Ti and W precursors highlighted in 2025, alongside a term-loan agreement executed in September 2025 to support growth amid robust demand for semiconductor materials.